OncXerna Therapeutics Company
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
Industry:
Clinical Development, Gene therapy, Preclinical Development
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
126500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-03-03
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership